Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
SLB Revenue Rises as Data-Center Demand Grows, Middle East Business Recovers
The company’s third-quarter revenue climbed 5.8% to $9.45 billion,...
New York couple names son Knickson Fyve after Knicks title chant
Late at night on June 13, as the final...
Vanessa Trump says she is ‘cancer-free’ after breast cancer treatment
Vanessa Trump, ex-wife of Donald Trump Jr., revealed Friday...